Technical Analysis for KALA - Kala Pharmaceuticals, Inc.
|Grade||Last Price||% Change||Price Change|
KALA closed up 0.65 percent on Tuesday, January 15, 2019, on 79 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
|See historical KALA trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 15||50 DMA Support||Bullish||1.20%|
|Jan 15||NR7||Range Contraction||1.20%|
|Jan 15||Inside Day||Range Contraction||1.20%|
|Jan 15||Wide Bands||Range Expansion||1.20%|
|Jan 15||Overbought Stochastic||Strength||1.20%|
|Jan 15||Up 3 Days in a Row||Strength||1.20%|
|Jan 14||50 DMA Support||Bullish||1.85%|
|Jan 14||Wide Bands||Range Expansion||1.85%|
|Jan 14||Overbought Stochastic||Strength||1.85%|
|Jan 11||Crossed Above 50 DMA||Bullish||3.52%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Kala Pharmaceuticals Inc. is a United States-based company that is developing ophthalmic treatments based on the Company’s Mucosal Penetrating Product (MPP) platform. The Company’s topical ocular MPP formulations enhance penetration of diverse therapeutic agents into ocular tissue, including those in the back of the eye, by facilitating penetration through the mucus layer of tear film. Its product development pipeline includes a 1% formulation of loteprednol etabonate to treat post-surgical ocular inflammation and pain; a 0.25% LE-MPP formulation for dry eye, blepharitis, and retinal disease, and a topically applied receptor tyrosine kinase inhibitir (RTKi-MPP) for the treatment of wet age-related macular degeneration (AMD).
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more KALA news...
|52 Week High||18.3|
|52 Week Low||4.03|
|200-Day Moving Average||11.2426|
|50-Day Moving Average||6.005|
|20-Day Moving Average||5.353|
|10-Day Moving Average||5.942|
|Average True Range||0.4432|
|Chandelier Exit (Long, 3 ATRs )||5.1604|
|Chandelier Exit (Short, 3 ATRs )||5.3596|
|Upper Bollinger Band||6.6965|
|Lower Bollinger Band||4.0095|
|Percent B (%b)||0.83|
|MACD Signal Line||-0.0992|
|Market Cap||151.18 Million|
|Num Shares||24.2 Million|
|Price-to-Earnings (P/E) Ratio||-0.19|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||6.60|
|Resistance 3 (R3)||6.56||6.40||6.54|
|Resistance 2 (R2)||6.40||6.31||6.42||6.52|
|Resistance 1 (R1)||6.32||6.25||6.36||6.36||6.50|
|Support 1 (S1)||6.08||6.07||6.12||6.12||5.98|
|Support 2 (S2)||5.92||6.01||5.94||5.96|
|Support 3 (S3)||5.84||5.92||5.94|
|Support 4 (S4)||5.88|